Can an Oxygen-Boosting drug help when all else fails?
NCT ID NCT07748299
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This program allows doctors to request NanO₂, an investigational drug that may help deliver oxygen to tissues, for patients with serious or life-threatening conditions like glioblastoma, respiratory distress, or ischemic stroke. It is for patients who have exhausted other treatments and cannot join a clinical trial. Each request is reviewed individually, and the drug is not FDA-approved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NanO₂ (NVX-108), an investigational oxygen-carrying drug
- What this could lead to
- If successful, this expanded access program could provide a potential treatment option for patients with life-threatening conditions who have no other choices.
- What could go wrong
- This is an early-stage, unapproved drug with unknown risks and benefits. Access is not guaranteed, and it may not work for every patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore swallowing after stroke?
- Can Brain-Triggered stimulation reawaken arms after stroke?
- Can gentle oscillations help premature babies breathe better?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- New imaging clues could sharpen brain tumor monitoring
- Can a virus injected into brain tumors fight recurrence?